- Novartis asked high court to set aside mandate allowing generic versions of multiple-sclerosis drug
- Novartis argued it is likely to win Supreme Court challenge
- https://www.reuters.com/legal/litigation/novartis-asks-us-supreme-court-pause-gilenya-ruling-halt-generic-rivals-2022-09-29/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.